AM Best Places Aetna Subsidiaries' Credit Ratings Under Review
AM Best has placed the credit ratings of Aetna Life Insurance Company and other Aetna Health & Life Group members under review with developing implications.
Stocks · News reference
CVS Health (NYSE:CVS) reported third-quarter financial results on Wednesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by Benzinga APIs. For
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
AM Best has placed the credit ratings of Aetna Life Insurance Company and other Aetna Health & Life Group members under review with developing implications.
CVS Health has appointed the Chief Data & Analytics Officer of J.P. Morgan to its board of directors, effective November 2026.
Goldman Sachs has revised its price target for CVS Health Corporation, lowering it from $120 to $115.
CVS Health announced plans to split into two independent publicly traded companies by the first half of 2028. The continuing CVS Health would retain Aetna, Caremark, and specialty pharmacy operations, while CVS Pharmacy would house retail stores and MinuteClinic. The company raised its 2026 adjusted EPS guidance to at least $8.20 and 2027 EPS to at least $8.65, driven by strong Aetna margin recovery and retail prescription growth, though Caremark faces 340B program headwinds and membership pressures in 2027.
The Dow jumped 1,569 points on Wednesday as the midterm result reset expectations for Washington. Oil fell more than 8%, giving consumer businesses a different backdrop while punishing energy shares. Democrats won